GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Accounts Payable & Accrued Expense

KAPA (Kairos Pharma) Accounts Payable & Accrued Expense : $1.53 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kairos Pharma Accounts Payable & Accrued Expense?

Kairos Pharma's quarterly accounts payable & accrued expense increased from Mar. 2024 ($1.89 Mil) to Jun. 2024 ($1.92 Mil) but then declined from Jun. 2024 ($1.92 Mil) to Sep. 2024 ($1.53 Mil).

Kairos Pharma's annual accounts payable & accrued expense increased from Dec. 2021 ($1.56 Mil) to Dec. 2022 ($1.63 Mil) but then declined from Dec. 2022 ($1.63 Mil) to Dec. 2023 ($1.59 Mil).

Kairos Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kairos Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kairos Pharma Accounts Payable & Accrued Expense Chart

Kairos Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
0.31 1.56 1.63 1.59

Kairos Pharma Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.59 1.89 1.92 1.53

Kairos Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kairos Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
2355 Westwood Boulevard, 139, Los Angeles, CA, USA, 90064
Website
https://kairospharma.com
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.